Hospital for Special Surgery, New York, NY, USA.
Hand (N Y). 2022 Mar;17(2):206-213. doi: 10.1177/1558944720928483. Epub 2020 Jun 7.
Patient-reported allergies (PRAs) are associated with suboptimal orthopaedic surgery outcomes and may serve as a proxy for mental health. While mental health disorders are known risk factors for increased opioid use, less is known about how PRAs impact opioid use after orthopedic surgery. The purpose of this study was to investigate the association between PRAs and postoperative opioid use, pain, and satisfaction following hand surgery. Patients who underwent ambulatory hand surgery at a single institution from May 2017 to March 2019 were retrospectively reviewed. Various scores, including the Mindfulness Attention Awareness Scale (MAAS), were collected preoperatively. Postoperatively, patients completed a 2-week pain diary, satisfaction, and visual analog scale (VAS) pain scores. Opioid consumption was converted to oral morphine equivalents (OMEs) using standard conversions. A total of 137 patients were divided into 2 groups based on presence (≥1) (n = 73) or absence (0) (n = 64) of PRAs. At baseline, the ≥ 1 PRA group had significantly higher female composition ( < .001) and pain ( < .001) and lower PROMIS mental health scores ( = .044). Postoperative OME consumption averaged 42.5 (range 0-416) in the entire cohort, with no differences between groups. Among patients with ≥ 1 PRA, increasing number of allergies significantly correlated with increasing OME consumption across all time points (week 1, = .016; week 2, = .001; total, = .005). The presence of PRAs did not impact postoperative narcotic usage, pain, or satisfaction. Increasing numbers of PRAs did, however, significantly correlate with higher narcotic use. These results may have implications for postoperative pain management in this population.
患者自述过敏史(PRAs)与骨科手术结果不理想有关,并且可能是心理健康的一个替代指标。虽然心理健康障碍是增加阿片类药物使用的已知危险因素,但对于 PRA 如何影响骨科手术后阿片类药物的使用知之甚少。本研究的目的是调查 PRAs 与手部手术后的术后阿片类药物使用、疼痛和满意度之间的关系。对 2017 年 5 月至 2019 年 3 月在一家机构接受门诊手部手术的患者进行回顾性分析。术前收集了各种评分,包括正念注意意识量表(MAAS)。术后,患者完成了为期 2 周的疼痛日记、满意度和视觉模拟评分(VAS)疼痛评分。阿片类药物的使用量通过标准换算转换为口服吗啡等效物(OME)。
总共 137 名患者根据是否存在(≥1)(n = 73)或不存在(0)(n = 64)PRAs 分为两组。在基线时,≥1 PRA 组的女性构成比显著更高(<.001),疼痛程度更高(<.001),而 PROMIS 心理健康评分更低(=.044)。整个队列的术后 OME 消耗量平均为 42.5(范围 0-416),两组之间没有差异。在≥1 PRA 的患者中,过敏数量的增加与所有时间点的 OME 消耗量的增加呈显著相关(第 1 周,=.016;第 2 周,=.001;总,=.005)。
PRA 的存在并不影响术后麻醉药物的使用、疼痛或满意度。然而,PRAs 的数量增加与更高的麻醉药物使用显著相关。这些结果可能对该人群的术后疼痛管理有影响。